Traumatic Brain Injury - Pipeline Review, H2 2017

Publisher Name :
Date: 11-Jul-2017
No. of pages: 252
Inquire Before Buying

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Traumatic Brain Injury - Pipeline Review, H2 2017, provides an overview of the Traumatic Brain Injury (Central Nervous System) pipeline landscape.

Traumatic brain injury happens when an external mechanical force causes brain damage. Traumatic brain injury usually results from a violent blow or jolt to the head or body. Symptoms include headache, dizziness, nausea or vomiting, mood changes, fatigue or drowsiness, difficulty sleeping and memory or concentration problems. Risk factor includes age. Certain types of traumatic brain injury increase the risk of developing Alzheimer's disease and coordination problems.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Traumatic Brain Injury - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Traumatic Brain Injury (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Traumatic Brain Injury (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Traumatic Brain Injury and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are 1, 6, 9, 55 and 8 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 10 and 1 molecules, respectively.

Traumatic Brain Injury (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

  • The pipeline guide provides a snapshot of the global therapeutic landscape of Traumatic Brain Injury (Central Nervous System).

  • The pipeline guide reviews pipeline therapeutics for Traumatic Brain Injury (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.

  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

  • The pipeline guide reviews key companies involved in Traumatic Brain Injury (Central Nervous System) therapeutics and enlists all their major and minor projects.

  • The pipeline guide evaluates Traumatic Brain Injury (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

  • The pipeline guide reviews latest news related to pipeline therapeutics for Traumatic Brain Injury (Central Nervous System)

Reasons to buy

  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

  • Find and recognize significant and varied types of therapeutics under development for Traumatic Brain Injury (Central Nervous System).

  • Classify potential new clients or partners in the target demographic.

  • Develop tactical initiatives by understanding the focus areas of leading companies.

  • Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.

  • Formulate corrective measures for pipeline projects by understanding Traumatic Brain Injury (Central Nervous System) pipeline depth and focus of Indication therapeutics.

  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Traumatic Brain Injury - Pipeline Review, H2 2017

Table of Contents

Table of Contents 2
Introduction 5
Traumatic Brain Injury - Overview 6
Traumatic Brain Injury - Therapeutics Development 7
Traumatic Brain Injury - Therapeutics Assessment 19
Traumatic Brain Injury - Companies Involved in Therapeutics Development 31
Traumatic Brain Injury - Drug Profiles 52
Traumatic Brain Injury - Dormant Projects 227
Traumatic Brain Injury - Discontinued Products 230
Traumatic Brain Injury - Product Development Milestones 231
Appendix 242

List of Tables

Number of Products under Development for Traumatic Brain Injury, H2 2017
Number of Products under Development by Companies, H2 2017
Number of Products under Development by Companies, H2 2017 (Contd..1), H2 2017
Number of Products under Development by Companies, H2 2017 (Contd..2), H2 2017
Number of Products under Development by Companies, H2 2017 (Contd..3), H2 2017
Number of Products under Development by Universities/Institutes, H2 2017
Products under Development by Companies, H2 2017
Products under Development by Companies, H2 2017 (Contd..1), H2 2017
Products under Development by Companies, H2 2017 (Contd..2), H2 2017
Products under Development by Companies, H2 2017 (Contd..3), H2 2017
Products under Development by Universities/Institutes, H2 2017
Number of Products by Stage and Target, H2 2017
Number of Products by Stage and Target, H2 2017 (Contd..1), H2 2017
Number of Products by Stage and Target, H2 2017 (Contd..2), H2 2017
Number of Products by Stage and Mechanism of Action, H2 2017
Number of Products by Stage and Mechanism of Action, H2 2017 (Contd..1), H2 2017
Number of Products by Stage and Mechanism of Action, H2 2017 (Contd..2), H2 2017
Number of Products by Stage and Route of Administration, H2 2017
Number of Products by Stage and Molecule Type, H2 2017
Traumatic Brain Injury - Pipeline by ALSP Inc, H2 2017
Traumatic Brain Injury - Pipeline by Apollo Endosurgery Inc, H2 2017
Traumatic Brain Injury - Pipeline by Aptinyx Inc, H2 2017
Traumatic Brain Injury - Pipeline by Athersys Inc, H2 2017
Traumatic Brain Injury - Pipeline by Beech Tree Labs Inc, H2 2017
Traumatic Brain Injury - Pipeline by Biogen Inc, H2 2017
Traumatic Brain Injury - Pipeline by Cantex Pharmaceuticals Inc, H2 2017
Traumatic Brain Injury - Pipeline by Cognosci Inc, H2 2017
Traumatic Brain Injury - Pipeline by Eustralis Pharmaceuticals Ltd, H2 2017
Traumatic Brain Injury - Pipeline by Intellect Neurosciences Inc, H2 2017
Traumatic Brain Injury - Pipeline by International Stem Cell Corp, H2 2017
Traumatic Brain Injury - Pipeline by Ischemix Inc, H2 2017
Traumatic Brain Injury - Pipeline by JT Pharmaceuticals Inc, H2 2017
Traumatic Brain Injury - Pipeline by Karyopharm Therapeutics Inc, H2 2017
Traumatic Brain Injury - Pipeline by Kyorin Pharmaceutical Co Ltd, H2 2017
Traumatic Brain Injury - Pipeline by Levolta Pharmaceuticals Inc, H2 2017
Traumatic Brain Injury - Pipeline by Lixte Biotechnology Holdings Inc, H2 2017
Traumatic Brain Injury - Pipeline by MandalMed Inc, H2 2017
Traumatic Brain Injury - Pipeline by Mapreg SAS, H2 2017
Traumatic Brain Injury - Pipeline by Neuralstem Inc, H2 2017
Traumatic Brain Injury - Pipeline by Neuren Pharmaceuticals Ltd, H2 2017
Traumatic Brain Injury - Pipeline by Neurofx Inc, H2 2017
Traumatic Brain Injury - Pipeline by NeuroNascent Inc, H2 2017
Traumatic Brain Injury - Pipeline by NeuroVive Pharmaceutical AB, H2 2017
Traumatic Brain Injury - Pipeline by New World Laboratories Inc, H2 2017
Traumatic Brain Injury - Pipeline by NoNO Inc, H2 2017
Traumatic Brain Injury - Pipeline by NuvOx Pharma LLC, H2 2017
Traumatic Brain Injury - Pipeline by Omeros Corp, H2 2017
Traumatic Brain Injury - Pipeline by Oxeia Biopharmaceuticals Inc, H2 2017
Traumatic Brain Injury - Pipeline by Prevacus Inc, H2 2017
Traumatic Brain Injury - Pipeline by QR Pharma Inc, H2 2017
Traumatic Brain Injury - Pipeline by RegeneRx Biopharmaceuticals Inc, H2 2017
Traumatic Brain Injury - Pipeline by Rubicon Biotechnology Inc, H2 2017
Traumatic Brain Injury - Pipeline by Sage Therapeutics Inc, H2 2017
Traumatic Brain Injury - Pipeline by SanBio Inc, H2 2017
Traumatic Brain Injury - Pipeline by STATegics Inc, H2 2017
Traumatic Brain Injury - Pipeline by Stemedica Cell Technologies Inc, H2 2017
Traumatic Brain Injury - Pipeline by SynZyme Technologies LLC, H2 2017
Traumatic Brain Injury - Pipeline by Tetra Discovery Partners LLC, H2 2017
Traumatic Brain Injury - Pipeline by vasopharm GmbH, H2 2017
Traumatic Brain Injury - Pipeline by VG Life Sciences Inc, H2 2017
Traumatic Brain Injury - Dormant Projects, H2 2017
Traumatic Brain Injury - Dormant Projects, H2 2017 (Contd..1), H2 2017
Traumatic Brain Injury - Dormant Projects, H2 2017 (Contd..2), H2 2017
Traumatic Brain Injury - Discontinued Products, H2 2017

List of Figures

Number of Products under Development for Traumatic Brain Injury, H2 2017
Number of Products under Development by Companies, H2 2017
Number of Products under Development by Universities/Institutes, H2 2017
Number of Products by Top 10 Targets, H2 2017
Number of Products by Stage and Top 10 Targets, H2 2017
Number of Products by Top 10 Mechanism of Actions, H2 2017
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2017
Number of Products by Top 10 Routes of Administration, H2 2017
Number of Products by Stage and Top 10 Routes of Administration, H2 2017
Number of Products by Top 10 Molecule Types, H2 2017
Number of Products by Stage and Top 10 Molecule Types, H2 2017
  • Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) - Pipeline Review, H2 2017
    Published: 29-Dec-2017        Price: US 2000 Onwards        Pages: 39
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Multiple System Atrophy - Pipeline Review, H2 2017, provides an overview of the Multiple System Atrophy (Central Nervous System) pipeline landscape. Multiple system atrophy (MSA) or Shy-Drager syndrome is a neurological disorder that impairs body's involuntary functions (blood pressure, heart rate, bladder function and digestion). Symptoms include rigid muscles, bradykinesia, Tremors, dysarthria, d......
  • Progressive Supranuclear Palsy - Pipeline Review, H2 2017
    Published: 29-Dec-2017        Price: US 2000 Onwards        Pages: 80
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Progressive Supranuclear Palsy - Pipeline Review, H2 2017, provides an overview of the Progressive Supranuclear Palsy (Central Nervous System) pipeline landscape. Progressive supranuclear palsy, also called Steele-Richardson-Olszewski syndrome is a rare neurodegenerative disease that leads to difficulty with balance, movement, vision, speech and swallowing. Symptoms include fatigue, headaches, dizz......
  • Neuropathic Pain - Pipeline Review, H2 2017
    Published: 29-Dec-2017        Price: US 2000 Onwards        Pages: 488
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Neuropathic Pain - Pipeline Review, H2 2017, provides an overview of the Neuropathic Pain (Central Nervous System) pipeline landscape. Neuropathic pain, or neuralgia, is a condition in which the sensory system is affected. It is commonly accompanied by tissue injury. The nerve fibres could be damaged resulting in the generation of abnormal signals. Neuropathic pain is also exhibited along with many......
  • Smoking Addiction - Pipeline Review, H2 2017
    Published: 29-Dec-2017        Price: US 2000 Onwards        Pages: 89
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Smoking Addiction - Pipeline Review, H2 2017, provides an overview of the Smoking Addiction (Central Nervous System) pipeline landscape. Smoking is addictive, people experience an uncontrollable dependence on cigarettes, which on stopping will cause severe mental, emotional or physical reactions. People addicted to smoking develop tolerance to nicotine. Nicotine acts on acetylcholine receptors caus......
  • Global and United States Alcohol Addiction Therapeutics In-Depth Research Report 2017-2022
    Published: 26-Dec-2017        Price: US 3190 Onwards        Pages: 110
    The report is based on the market historical data from 2012 to 2016 and forecast the market trend from 2017 to 2022. This report focuses on the U.S. market and presents volume and value of market share by players, by regions, by product type, by consumers and also changes in prices. As an in-depth report, it covers all details inside analysis and opinions in Alcohol Addiction Therapeutics industry. Major Companies - AstraZeneca Plc - BioCorRx Inc......
  • Global Alcohol Addiction Therapeutics Sales Market Report 2018
    Published: 25-Dec-2017        Price: US 4000 Onwards        Pages: 113
    In this report, the global Alcohol Addiction Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Alcohol Addiction Therapeutics for these regions, from 2012 to 2022 (forecast), covering - United States - China ......
  • 2015-2023 World Gabapentin Market Research Report by Product Type, End-User / Application and Regions / Countries
    Published: 19-Dec-2017        Price: US 2800 Onwards        Pages: 136
    Summary Gabapentin is an anti-epileptic medication, also called an anticonvulsant. It affects chemicals and nerves in the body that are involved in the cause of seizures and some types of pain. This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions. M......
  • Encephalopathy - Pipeline Review, H2 2017
    Published: 13-Dec-2017        Price: US 2000 Onwards        Pages: 58
    Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Encephalopathy - Pipeline Review, H2 2017, provides an overview of the Encephalopathy (Central Nervous System) pipeline landscape. Encephalopathy is a term for any diffuse disease of the brain that alters brain function or structure. Symptoms include seizures, difficulty speaking or swallowing, trembling, involuntary twitching and muscle weakness. Causes include traumas......
  • Canavan Disease - Pipeline Review, H2 2017
    Published: 13-Dec-2017        Price: US 2000 Onwards        Pages: 27
    Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Canavan Disease - Pipeline Review, H2 2017, provides an overview of the Canavan Disease (Central Nervous System) pipeline landscape. Canavan disease is a gene-linked neurological disorder in which the brain degenerates into spongy tissue riddled with microscopic fluid-filled spaces. Cause includes a mutation in the gene which directs the production of the enzyme asparto......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs